You have 9 free searches left this month | for more free features.

trilaciclib

Showing 1 - 17 of 17

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Tumors Trial in Guangzhou (Trilaciclib, Epirubicin, Cyclophosphamide)

Not yet recruiting
  • Breast Neoplasms
  • Trilaciclib
  • +7 more
  • Guangzhou, Gangdong, China
    Sun-yat sen university cancer center
Jul 30, 2023

Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Trilaciclib
  • +2 more
  • (no location specified)
May 22, 2023

Metastatic Triple-Negative Breast Cancer Trial in Charlotte (Trilaciclib, Pembrolizumab, Gemcitabine)

Not yet recruiting
  • Metastatic Triple-Negative Breast Cancer
  • Trilaciclib
  • +3 more
  • Charlotte, North Carolina
    Levine Cancer Institute
Aug 31, 2023

Lung Cancer, Small-cell Lung Cancer Trial in Lebanon (Trilaciclib, Lurbinectedin)

Recruiting
  • Lung Cancer
  • Small-cell Lung Cancer
  • Lebanon, New Hampshire
    Dartmouth Hitchcock Medical Center
Nov 9, 2022

Advanced Squamous Non-Small-Cell Lung Cancer Trial (Trilaciclib, Carboplatin, Paclitaxel)

Not yet recruiting
  • Advanced Squamous Non-Small-Cell Lung Cancer
  • Trilaciclib
  • +3 more
  • (no location specified)
Jun 11, 2023

Triple Negative Breast Cancer, Breast Cancer Trial in United States (Trilaciclib, Cylophosphamide, Doxorubicin)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Breast Cancer
  • Trilaciclib
  • +5 more
  • Los Alamitos, California
  • +6 more
Jan 25, 2023

Extensive-stage Small-cell Lung Cancer Trial in Haikou (Trilaciclib)

Active, not recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Trilaciclib
  • Haikou, Hainan, China
    Hainan General Hospital
Jun 13, 2022

Triple Negative Breast Cancer Trial in United States (Trilaciclib, Sacituzumab Govitecan-hziy)

Recruiting
  • Triple Negative Breast Cancer
  • Trilaciclib
  • Sacituzumab Govitecan-hziy
  • Chandler, Arizona
  • +21 more
Oct 25, 2022

Metastatic NSCLC, NSCLC, Lung Cancer Trial in United States (Trilaciclib, Placebo, Docetaxel)

Terminated
  • Metastatic Non-Small Cell Lung Cancer
  • +2 more
  • Trilaciclib
  • +2 more
  • Phoenix, Arizona
  • +11 more
Feb 11, 2022

Extensive-stage Small-cell Lung Cancer Trial in Changchun (Trilaciclib)

Recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Trilaciclib
  • Changchun, China
    Jilin Cancer Hopspital
Sep 5, 2021

Myelosuppression Adult, Chemotherapeutic Toxicity, Small Cell Lung Cancer Trial (Trilaciclib)

Approved for marketing
  • Myelosuppression Adult
  • +2 more
  • Trilaciclib
  • (no location specified)
Mar 17, 2021

Small Cell Lung Cancer Trial in Worldwide (Trilaciclib, Placebo, Carboplatin)

Terminated
  • Small Cell Lung Cancer
  • Trilaciclib
  • +4 more
  • Beverly Hills, California
  • +44 more
Apr 8, 2022

Colorectal Cancer Metastatic, Myelosuppression-Adult, Chemotherapeutic Toxicity Trial in Worldwide (Trilaciclib, Placebo)

Active, not recruiting
  • Colorectal Cancer Metastatic
  • +2 more
  • Trilaciclib
  • Placebo
  • Tucson, Arizona
  • +81 more
Jan 3, 2023

Small Cell Lung Cancer Trial in Worldwide (Trilaciclib, Placebo, Topotecan)

Terminated
  • Small Cell Lung Cancer
  • Trilaciclib
  • +2 more
  • Hot Springs, Arkansas
  • +49 more
May 12, 2022

Triple-Negative Breast Tumors, Breast Tumor, Breast Cancer Trial in Worldwide (Trilaciclib, Gemcitabine, Carboplatin)

Terminated
  • Triple-Negative Breast Neoplasms
  • +3 more
  • Trilaciclib
  • +2 more
  • Tucson, Arizona
  • +53 more
Feb 24, 2022

TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial in Worldwide (Trilaciclib, Placebo, Gemcitabine)

Active, not recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Breast Cancer
  • Trilaciclib
  • +3 more
  • Birmingham, Alabama
  • +111 more
Oct 25, 2022

Small Cell Lung Cancer Trial in Worldwide (Carboplatin, Placebo, Trilaciclib)

Completed
  • Small Cell Lung Cancer
  • Hot Springs, Arkansas
  • +39 more
Aug 11, 2020